To make a greater impact on your audience, shift from one-way delivery to an active experience with interactive slides.

Meiji Seika Pharma will present 10 studies on Nacubactam at ESCMID Global 2026 including Phase III Integral-2 results in patients with CRE infections.

For the past 15 years, Gerald W. Smetana, MD, MACP, from Harvard Medical School, has given a presentation at the ACP Internal ...

Automate your content creation with HeyGen Avatar V. Turn a 15-second clip into a customizable digital twin, translate videos ...

SELLAS Life Sciences (SLS) is rated 'Hold' due to pending phase 3 REGAL data for GPS in AML after CR2, a major 2026 catalyst.

Independent Bank Corporation reported first quarter 2026 net income of $16.9 million or $0.81 per diluted share versus net ...

Researchers from The University of Texas MD Anderson Cancer Center will present initial data from six clinical trials during minisymposia at this week’s American Association for Cancer Research (AACR) ...

Mayo Clinic Comprehensive Cancer Center scientists, physicians and trainees will present nearly 60 studies on emerging cancer therapies, diagnostics and prevention strategies at the 2026 American ...

Learn how to build rapport, open doors to new opportunities and accelerate your career with everyday conversation in the ...

Hosted by the CCIU, the event provided a forum for open dialogue, shared learning, and relationship-building, reinforcing the ...

The Undergraduate Senate passed a bill calling for students with OAE accommodations to be allowed to form housing groups.